HER2-positive Advanced Breast Cancer Clinical Trials
1 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute87 enrolled1 locationNCT06595563
Recruiting
Phase 3
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
HER2-positive Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.416 enrolled69 locationsNCT07047365
Recruiting
Phase 2
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
HER2-positive Advanced Breast CancerBrain MetastasesRadiotherapy
Henan Cancer Hospital224 enrolled1 locationNCT07100600
Recruiting
Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
HER2-positive Advanced Breast Cancer
Zhejiang Cancer Hospital100 enrolled1 locationNCT05856383